Globeflex Capital L P Ironwood Pharmaceuticals Inc Transaction History

Globeflex Capital L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$9.9 - $12.43 $348,222 - $437,212	-35,174 Reduced 22.46%	121,452 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $480,494 - $586,638	47,386 Added 43.38%	156,626 $1.62 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $448,490 - $523,740	37,625 Added 52.54%	109,240 $1.43 Million
Q2 2021 Aug 12, 2021	BUY	$10.16 - $13.11 $1,229 - $1,586	121 Added 0.17%	71,615 $922,000
Q4 2020 Feb 11, 2021	BUY	$9.05 - $12.2 $155,153 - $209,156	17,144 Added 31.54%	71,494 $814,000
Q1 2020 May 13, 2020	BUY	$8.58 - $14.01 $90,381 - $147,581	10,534 Added 24.04%	54,350 $548,000
Q4 2019 Feb 07, 2020	BUY	$8.22 - $14.0 $360,167 - $613,424	43,816 New	43,816 $583,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.